A. S. Paul and others (2003). “The management of soft-tissue sarcomas of the extremities”. Current Orthopaedics17: 124–133. doi:10.1054/cuor.2002.0314.
Pfeifer JD, Hill DA, O'Sullivan MJ, Dehner LP (2000). “Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?”. Histopathology37 (6): 485–500. doi:10.1046/j.1365-2559.2000.01107.x. PMID11122430.
Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L (2003). “Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases”. Cancer98 (12): 2700–7. doi:10.1002/cncr.11840. PMID14669292.
nih.gov
pubmed.ncbi.nlm.nih.gov
Coindre JM (2006). “Grading of soft tissue sarcomas: review and update”. Arch. Pathol. Lab. Med.130 (10): 1448–53. PMID17090186.
Pfeifer JD, Hill DA, O'Sullivan MJ, Dehner LP (2000). “Diagnostic gold standard for soft tissue tumours: morphology or molecular genetics?”. Histopathology37 (6): 485–500. doi:10.1046/j.1365-2559.2000.01107.x. PMID11122430.
Coindre JM, Pelmus M, Hostein I, Lussan C, Bui BN, Guillou L (2003). “Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases”. Cancer98 (12): 2700–7. doi:10.1002/cncr.11840. PMID14669292.
Ladanyi M, Antonescu CR, Leung DH, et al (2002). “Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients”. Cancer Res.62 (1): 135–40. PMID11782370.
Lewis JJ, Antonescu CR, Leung DH, et al (2000). “Synovial sarcoma: a multivariate analysis of prognostic factors in 112 patients with primary localized tumors of the extremity”. J. Clin. Oncol.18 (10): 2087–94. PMID10811674.